Jerusalem, May 18, 2014 – Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced that results from a real-life, retrospective, observational study of QVAR® will be presented at the American ...
First and Only Breath-Actuated Aerosol Inhaled Corticosteroid in the United States Designed to Help Eliminate the Need for Hand-Breath Coordination JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical ...
Teva announced that the FDA has approved Qvar (beclomethasone dipropionate HFA) with a dose counter for the ongoing treatment of asthma as a preventative therapy in patients ≥5 years of age. In 2003, ...
The efficacy of inhaled steroids in spontaneously breathing infants with established bronchopulmonary dysplasia (BPD) is debatable. The inhaled steroid hydrofluoalkane-beclomethasone dipropionate ...
JERUSALEM — Teva Pharmaceutical on Friday announced that the Food and Drug Administration approved the use of QVAR (beclomethasone dipropionate HFA) with a dose counter for the treatment of asthma in ...
* Teva Pharmaceutical Industries Ltd - plans to discontinue sales of this current QVAR MDI formulation upon launch of qvarredihaler in Q1 of 2018 * Teva Pharmaceutical Industries - QVAR redihaler ...
Objective: To assess the bioequivalence of beclomethasone dipropionate (BDP) delivered from a press-and-breathe (PB) inhaler and a breath-actuated inhaler (Autohaler TM, AH). Design: Two randomised, ...
MIAMI--(BUSINESS WIRE)--Oct. 1, 2003--IVAX Corporation (AMEX:IVX) (LSE:IVX.L) has completed its previously announced agreement with the 3M Company (NYSE:MMM) in which IVAX assumes exclusive rights to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback